![Veterinary Sciences | Free Full-Text | Fusion Expression and Immune Effect of PCV2 Cap Protein Tandem Multiantigen Epitopes with CD154/GM-CSF | HTML Veterinary Sciences | Free Full-Text | Fusion Expression and Immune Effect of PCV2 Cap Protein Tandem Multiantigen Epitopes with CD154/GM-CSF | HTML](https://www.mdpi.com/vetsci/vetsci-08-00211/article_deploy/html/images/vetsci-08-00211-g003.png)
Veterinary Sciences | Free Full-Text | Fusion Expression and Immune Effect of PCV2 Cap Protein Tandem Multiantigen Epitopes with CD154/GM-CSF | HTML
![PDF) First-in-Human Phase I Study of MP0250, a First-in-Class DARPin Drug Candidate Targeting VEGF and HGF, in Patients With Advanced Solid Tumors PDF) First-in-Human Phase I Study of MP0250, a First-in-Class DARPin Drug Candidate Targeting VEGF and HGF, in Patients With Advanced Solid Tumors](https://i1.rgstatic.net/publication/346931452_First-in-Human_Phase_I_Study_of_MP0250_a_First-in-Class_DARPin_Drug_Candidate_Targeting_VEGF_and_HGF_in_Patients_With_Advanced_Solid_Tumors/links/5fd29dd445851568d154ced6/largepreview.png)
PDF) First-in-Human Phase I Study of MP0250, a First-in-Class DARPin Drug Candidate Targeting VEGF and HGF, in Patients With Advanced Solid Tumors
![How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definition | Annals of the Rheumatic Diseases How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definition | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/76/8/1381/F1.large.jpg)
How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definition | Annals of the Rheumatic Diseases
![Time to minimal disease activity in relation to quality of life, productivity, and radiographic damage 1 year after diagnosis in psoriatic arthritis | Arthritis Research & Therapy | Full Text Time to minimal disease activity in relation to quality of life, productivity, and radiographic damage 1 year after diagnosis in psoriatic arthritis | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-019-1811-4/MediaObjects/13075_2019_1811_Fig1_HTML.png)
Time to minimal disease activity in relation to quality of life, productivity, and radiographic damage 1 year after diagnosis in psoriatic arthritis | Arthritis Research & Therapy | Full Text
![Burden of Psoriatic Arthritis According to Different Definitions of Disease Activity: Comparing Minimal Disease Activity and the Disease Activity Index for Psoriatic Arthritis - Wervers - 2018 - Arthritis Care & Research - Wiley Online Library Burden of Psoriatic Arthritis According to Different Definitions of Disease Activity: Comparing Minimal Disease Activity and the Disease Activity Index for Psoriatic Arthritis - Wervers - 2018 - Arthritis Care & Research - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2138dd0c-8bc2-4794-9dfa-9ce644a35d4a/acr23571-fig-0001-m.png)
Burden of Psoriatic Arthritis According to Different Definitions of Disease Activity: Comparing Minimal Disease Activity and the Disease Activity Index for Psoriatic Arthritis - Wervers - 2018 - Arthritis Care & Research - Wiley Online Library
![Switching first-line targeted therapy after not reaching low disease activity within 6 months is superior to conservative approach: a propensity score-matched analysis from the ATTRA registry | SpringerLink Switching first-line targeted therapy after not reaching low disease activity within 6 months is superior to conservative approach: a propensity score-matched analysis from the ATTRA registry | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-020-02393-8/MediaObjects/13075_2020_2393_Fig2_HTML.png)